Compare QTRX & CLDT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | QTRX | CLDT |
|---|---|---|
| Founded | 2007 | 2009 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Real Estate Investment Trusts |
| Sector | Industrials | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 306.0M | 362.9M |
| IPO Year | 2017 | N/A |
| Metric | QTRX | CLDT |
|---|---|---|
| Price | $6.34 | $7.67 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $11.33 | $9.50 |
| AVG Volume (30 Days) | ★ 534.0K | 236.6K |
| Earning Date | 04-03-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 4.67% |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $37,632,000.00 | N/A |
| Revenue This Year | N/A | $1.76 |
| Revenue Next Year | $28.28 | N/A |
| P/E Ratio | ★ N/A | $610.21 |
| Revenue Growth | ★ 64.52 | N/A |
| 52 Week Low | $4.15 | $5.83 |
| 52 Week High | $8.77 | $8.42 |
| Indicator | QTRX | CLDT |
|---|---|---|
| Relative Strength Index (RSI) | 50.85 | 58.60 |
| Support Level | $6.23 | $6.63 |
| Resistance Level | $6.38 | $7.74 |
| Average True Range (ATR) | 0.38 | 0.24 |
| MACD | 0.10 | 0.00 |
| Stochastic Oscillator | 62.02 | 54.07 |
Quanterix Corp is a life sciences company that focuses on developing an ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. The Simoa bead-based and planar array platforms designed by the company enable customers to reliably detect protein biomarkers in low concentrations in blood, serum, and other fluids that are undetectable using conventional, analog immunoassay technologies. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, Instruments, HD-X Automated Immunoassay Analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, Simoa Accelerator Laboratory and others. Geographically, It operates in North America, EMEA and Asia Pacific.
Chatham Lodging Trust is a U.S.-based real estate investment trust that invests in upscale extended-stay hotels. The firm operates across various states in the U.S., including California, New York, Texas, Florida, Minnesota, Massachusetts, and Pennsylvania among others. Substantially all of the company's assets are held and operated by its Operating Partnership, Chatham Lodging, LP. Chatham Lodging LP and its subsidiaries lease the overall company's hotels. The firm operates through a single segment because of the similar economic characteristics of its hotels. Chatham's revenue streams include Room, Food and beverage, and Other. Room comprises the majority of total revenue. Chatham's hotels operate under brands which include, Hilton, Marriott, and Hyatt.